UK Chooses Pfizer And Moderna For COVID-19 Boosters, But Questions Remain On Unpublished Trial Data
AstraZeneca's Vaccine Not Selected
Executive Summary
The UK’s choice of the mRNA vaccines as COVID-19 boosters is no surprise – but not releasing the key study data behind the decision is.
You may also be interested in...
AstraZeneca CEO Rues Reality Of Vaccine Inequity
The UK major’s hopes of creating a vaccine for the world during the COVID-19 pandemic have been hampered by political self-interest and nationalism, according to a BBC documentary.
Biden’s Trump Moment? COVID Booster Messaging Complicated After Top FDA Scientists Raise Doubts
As questions of political interference continue to swirl around the issue of whether additional vaccine shots will be needed, the Biden administration is facing communication challenges commonly seen with his predecessor, Donald Trump.
UK Trial Could Help Pick Best Covid Vaccine Boosters
Results will be important in fight against new variants, for second-generation vaccines and AstraZeneca’s controversy-hit jab.